Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $260

Benzinga · 1d ago
Evercore ISI Group analyst Gavin Clark-Gartner maintains AbbVie (NYSE:ABBV) with a Outperform and raises the price target from $246 to $260.